Pharmaceutical

BridgeBio Oncology Therapeutics launches with $200m funding

BridgeBio Pharma has announced the launch of BridgeBio Oncology Therapeutics (BBOT), underpinned by $200m of private external capital.

May 5, 2024 - 00:00
BridgeBio Oncology Therapeutics launches with $200m funding
BridgeBio Pharma has announced the launch of BridgeBio Oncology Therapeutics (BBOT), underpinned by $200m of private external capital.
Read the original article

Tags:

Previous Article

NHS to provide Pfizer’s Voxelotor to treat sickle cell disease

Next Article

Optimisation in operations: from theory to practice

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Climate change may aggravate multiple sclerosis

Climate change may aggravate multiple sclerosis

Jun 6, 2024

These are the need-to-know biotech stories from this weekend

These are the need-to-know biotech stories from this we...

Nov 13, 2023

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihoo...

Feb 20, 2024